Average Co-Inventor Count = 5.45
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (34 from 2,079 patents)
2. Vanderbilt University (3 from 1,163 patents)
3. Janssen Pharmaceuticals, Inc. (2 from 159 patents)
4. Addex Pharma, S.a. (2 from 37 patents)
39 patents:
1. 12006302 - Tau PET imaging ligands
2. 11168068 - Tau PET imaging ligands
3. 11045562 - Radiolabelled mGluR2/3 PET ligands
4. 11033641 - Radiolabelled mGluR2/3 pet ligands
5. 10967078 - Radiolabelled mGluR2 PET ligands
6. 10604523 - 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives
7. 10584129 - Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors
8. 10519162 - 6,7-dihydropyrazolo[1,5-α]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptors
9. 10512646 - Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors
10. 10112949 - 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptors
11. 10106542 - Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors
12. 10005785 - Substituted 6,7-dihydropyrazolo[1,5-a] pyrazines as negative allosteric modulators of mGlUR2 receptors
13. 10005786 - Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of MGLUR2 receptors
14. 9669035 - Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-A]]quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological of metabolic disorders
15. 9266834 - 1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors